[Hyderabad 18th, June 2025] — According to Clearview Market Insights, the Europe continuous bioprocessing market is expected to grow from USD 770 million in 2024 to USD 1.78 billion by 2031, registering a CAGR of 12.4%. As biopharma companies accelerate innovation in biologics, vaccines, and advanced therapies, continuous biomanufacturing has emerged as a transformative solution to address scale, cost, and time-to-market challenges.
Request Sample @ https://clearviewmarketinsights.com/report-details/europe-continuous-bioprocessing-market/
Continuous bioprocessing offers benefits such as a reduced facility footprint, lower buffer consumption, real-time process monitoring, and greater product consistency. It enables companies to manage smaller and more frequent production runs, which are ideal for targeted therapies and biosimilars.
Continuous manufacturing is reshaping how biologics are produced in Europe. The shift reflects a deeper need for agility, quality, and scalability—especially as cell and gene therapies move into commercial pipelines," said a CVMI bioprocessing analyst.
Germany and Switzerland lead adoption due to strong biologics infrastructure and regulatory clarity. The UK, Ireland, and the Nordics are rapidly embracing continuous technologies through CDMO partnerships and modular plant investments.
Leading players such as Sartorius, Merck, Cytiva, and Lonza are broadening their portfolios in perfusion bioreactors, AI-integrated PAT tools, and disposable chromatography modules to enhance multiproduct operations.
As regulatory bodies such as EMA and PIC/S promote adoption through updated quality frameworks, the market is set for rapid expansion among both established manufacturers and emerging biotech firms.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
